P.A.W. Capital Corp Oncocyte Corp Transaction History

P.A.W. Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$1.38 - $2.63 $275,586 - $525,211	-199,700 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$1.2 - $1.89 $360 - $567	-300 Reduced 0.15%	199,700 $278,000
Q2 2020 Jul 27, 2020	SELL	$1.91 - $3.45 $286,500 - $517,500	-150,000 Reduced 42.86%	200,000 $382,000
Q1 2020 May 08, 2020	BUY	$1.76 - $3.02 $176,000 - $302,000	100,000 Added 40.0%	350,000 $858,000
Q4 2019 Jan 28, 2020	BUY	$1.51 - $2.27 $377,500 - $567,500	250,000 New	250,000 $563,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $256M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.